STAT

NOVEMBER 14, 2023

A class action lawsuit was filed Tuesday against UnitedHealth Group and a subsidiary alleging that they are illegally using an algorithm to deny rehabilitation care to seriously ill patients, even though the companies know the algorithm has a high error rate. The class action suit, filed on behalf of deceased patients who had a UnitedHealthcare Medicare Advantage plan and their families by the California-based Clarkson Law Firm, follows the publication of a STAT investigation Tuesday.

Nursing Homes 364

Nursing Homes Documentation 364

PharmaVoice

NOVEMBER 14, 2023

Johnson & Johnson Innovative Medicine’s director of diversity, equity and inclusion in clinical trials shares key strategies for making DEI work.

147

147

STAT

NOVEMBER 14, 2023

The nation’s largest health insurance company pressured its medical staff to cut off payments for seriously ill patients in lockstep with a computer algorithm’s calculations, denying rehabilitation care for older and disabled Americans as profits soared, a STAT investigation has found. UnitedHealth Group has repeatedly said its algorithm, which predicts how long patients will need to stay in rehab, is merely a guidepost for their recoveries.

Health Insurance Companies 364

Health Insurance Companies Documentation 364

Pharma Times

NOVEMBER 14, 2023

The terminal condition currently affects around 5,000 people in the UK - News - PharmaTimes

140

140

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 14, 2023

America’s trust in scientists and positive views of science has continued to decline, according to a new report. The Pew Research Center, a nonpartisan think tank, asked a random sample of 8,842 American adults this fall about their views on science and scientists. They found that roughly a quarter of Americans — 27% — said they have not too much or no confidence in scientists to act in the public’s best interests, compared to 12% who said the same in April 2020.

333

333

Pharma Times

NOVEMBER 14, 2023

The projects will explore early-stage ideas at the frontiers of bioscience - News - PharmaTimes

133

133

PharmaVoice

NOVEMBER 14, 2023

For Sarepta — and DMD patients — there’s a lot riding on the treatment’s next steps.

130

130

STAT

NOVEMBER 14, 2023

In Stockton, California, almost 60% of the city’s 320,000 residents are prediabetic or living with diabetes. Shane Bailey, a 72-year-old longtime resident and U.S. Coast Guard veteran, is one of them. And because she lives in a neighborhood that is considered a food desert because it lacks nearby grocery stores, it can be a huge challenge to access healthy, affordable food.

Grocery Stores 278

Grocery Stores Diabetes 278

BioPharma Dive

NOVEMBER 14, 2023

The Series A round for three-year-old startup VectorY is one of the largest private financings in Europe this year, Forbion said.

119

119

STAT

NOVEMBER 14, 2023

I want to bring your attention to a vitally important  investigation  STAT has published today. For more than a year, our reporters have documented how the use of artificial intelligence is driving denial of claims or delaying treatment for seriously ill patients. This latest story goes even deeper, establishing how the denial of claims was by design.

Health Insurance Companies 250

Health Insurance Companies Documentation 250

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

NOVEMBER 14, 2023

AZ’s oncology hopes dented as Imfinzi flunks NSCLC trial Phil.

114

114

STAT

NOVEMBER 14, 2023

The announcement by the Center for Medicare and Medicaid Services that ten drugs will be subject to price negotiation under the Inflation Adjustment Act has unleashed a storm of debate. Most observers agree that the negotiations will reduce spending for both consumers and taxpayers. The real dispute centers on whether the prospect of price negotiations will reduce future innovation by shrinking the expected future profits for patented drugs.

Vaccines 229

Vaccines 229

Big Molecule Watch

NOVEMBER 14, 2023

Regeneron filed a Complaint on November 8 against Celltrion in the U.S. District Court for the Northern District of West Virginia, alleging infringement of thirty-eight patents under the BPCIA based on Celltrion’s submission of an aBLA for CT-P42, a proposed biosimilar of EYLEA (aflibercept), and Celltrion’s provision of Notice of Commercial Marketing with respect to the same.

Biosimilars 114

Biosimilars 114

STAT

NOVEMBER 14, 2023

Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds in search of creatures to annoy and neighbors sleeping late. As for us, we are as busy as ever hunting and gathering items of interest. We trust you have your own hectic agendas.

Chemotherapy 223

Chemotherapy 223

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 14, 2023

Resilience, empathy, and gratitude. A personal battle with breast cancer. Mike.

112

112

STAT

NOVEMBER 14, 2023

PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

Hospitals 220

Hospitals 220

European Pharmaceutical Review

NOVEMBER 14, 2023

The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country.

Pharmaceutical Manufacturing 110

Pharmaceutical Manufacturing 110

STAT

NOVEMBER 14, 2023

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Bon apétit, offsets are served Whenever lawmakers get around to actually making decisions about funding the government, leaders try to balance measures that save the government money with those that cost the government money.

208

208

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

NOVEMBER 14, 2023

AHA: First data backs AskBio’s heart failure gene therapy Phil.

109

109

STAT

NOVEMBER 14, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest twist in the Ozempic panic, polarizing data in genome editing, and another biotech in search of “strategic alternatives.

Drug Pricing 163

Drug Pricing Drug Development 163

PioneerRx

NOVEMBER 14, 2023

The most wonderful time of the year is slowly approaching. Temperatures are falling, days are getting shorter (thanks, daylight savings), and holiday lights are.

106

106

BioPharma Dive

NOVEMBER 14, 2023

The lobbying group urged broader health insurance coverage for treating obesity, including with GLP-1 agonists like Wegovy.

106

106

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

NOVEMBER 14, 2023

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass. On 1 October 2023, the final, official version of the chapter was published.

Packaging 105

Packaging Vaccines Documentation 105

Welltopia Pharmacy

NOVEMBER 14, 2023

Calcium Foods for Bones: Boost Bone Health Effectively 1.

105

105

pharmaphorum

NOVEMBER 14, 2023

Autifony swings $770.5m deal with Jazz for CNS drugs Phil.

102

102

Pharmafile

NOVEMBER 14, 2023

Ipsen and Medision Pharma have announced that Health Canada has approved Bylvay (odevixibat) for the treatment of pruritis in patients aged six months or older with Progressive Familial Intrahepatic Cholestasis (PFIC). Bylvay is the first medication approved in Canada for this indication. Both companies are part of a multiregional partnership in Canada and Israel in […] The post Health Canada approves Ipsen and Medision Pharma’s Bylvay for pruritus treatment appeared first on Pharmafile.

101

101

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

NOVEMBER 14, 2023

Owlstone Medical's exegenous volatile organic compound (EVOC) breath test can reveal signs of liver cirrhosis and portal hypertension, a study has found.

Compounding 99

Compounding 99

European Pharmaceutical Review

NOVEMBER 14, 2023

Outsourcing regulatory activities in pharma Here, EPR’s Editor explores some key considerations, approaches and strategies for pharmaceutical companies looking to outsource regulatory activities. Accelerating drug development for simple and complex drug programmes Quotient Sciences leverages more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation e

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies 98

PharmExec

NOVEMBER 14, 2023

Novo Nordisk said it will continue providing Levemir vials and the Levemir FlexPen for diabetes control while supplies last, until the full product discontinuation at the end of 2024.

Diabetes 97

Diabetes 97

European Pharmaceutical Review

NOVEMBER 14, 2023

Ajinomoto Co., Inc. is set to acquire Forge Biologics, a viral vector and plasmid contract development and manufacturing organisation (CDMO) and clinical-stage therapeutics company. According to Forge Biologics, the acquisition is an all-cash deal for $620 million, which is Forge’s enterprise value on a cash-free and debt-free basis. The equity value attributable to unitholders of Forge Biologics is approximately $554 million.

98

98

pharmaphorum

NOVEMBER 14, 2023

Pharma’s engagement with HCPs evolving, finds new poll Phil.

96

96